Status:
UNKNOWN
Study to Assess the Effect of Intravenous Supplementation of Omega-3 Fatty Acids on Outcome of Recipients in Living Donor Liver Transplantation
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
Liver Transplantation
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
Brief Summary
In this study, the investigators aim to analyse the effect of Omega 3 fatty acid supplementation on recipients undergoing living donor liver transplantation. In Group A, the patients receive Omega 3 f...
Eligibility Criteria
Inclusion
- All elective liver transplant recipients
- Adult patients
- Those who consent
Exclusion
- Liver transplantation for fulminant hepatic failure
- Re-transplantation
- Known allergy to the study emulsion
Key Trial Info
Start Date :
December 2 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2019
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT04030065
Start Date
December 2 2018
End Date
November 30 2019
Last Update
July 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of liver and biliary Sciences
New Delhi, India, 110070